Benzalkonium chloride (BAK), a detergent and preservative found in health care and household products, is an established irritant, yet BAK is seldom considered to cause allergic contact dermatitis. We have, however, observed positive patch test reactions more often than is typically reported. From 2001 through 2005 and 2006 through 2010, BAK was among the top 10 most frequent allergens in our standard series.
Objective
The aim of this study was to review the Mayo Clinic experience from 2000 to 2012 with patch testing to BAK.
Methods
An electronic patch test database was used to acquire results of patients who underwent patch testing for BAK 0.1% aqueous after it was introduced to the standard series in 2000 until 2012. Previous reports (1998–2000, 2001–2005, 2006–2010) from our institution were also reviewed.
Conclusions
Our study showed BAK to be an allergen of increasing importance. From 1998 through 2000, 2001 through 2005, and 2006 through 2010, the rate of allergic patch test results to BAK increased. More than half of the reactions in each period studied were graded as macular erythema, with at least one third of all reactions deemed to be relevant. Irritancy rates were consistently low.
WillisCM, YoungE, BrandonDR, et al.Immunopathological and ultrastructural findings in human allergic and irritant contact dermatitis. Br J Dermatol, 1986; 115(3): 305–316.
7.
FisherAA, StillmanMA. Allergic contact sensitivity to benzalkonium chloride: cutaneous, ophthalmic, and general medical implications. Arch Dermatol, 1972; 106: 169–171.
Ortiz-FrutosFJ, ArgilaD, RiveraR, et al.Allergic contact dermatitis from benzalkonium chloride used as a denaturant of ethanol. Contact Dermatitis, 1996; 35(5): 302.
15.
StanfordD, GeorgourasK. Allergic contact dermatitis from benzalkonium chloride in plaster of Paris. Contact Dermatitis, 1996; 35(6): 371–372.
ParkHJ, KangHA, LeeJY, et al.Allergic contact dermatitis from benzalkonium chloride in an antifungal solution. Contact Dermatitis, 2000; 42(5): 306–307.
18.
ChowdhuryMM, StathamBN. Allergic contact dermatitis from dibutyl phthalate and benzalkonium chloride in Timodine cream. Contact Dermatitis, 2002; 46(1): 57.
19.
HannS, HughesTM, StoneNM. Flexural allergic contact dermatitis to benzalkonium chloride in antiseptic bath oil. Br J Dermatol, 2007; 157(4): 795–798.
20.
CusanoF, LucianoS. Contact allergy to benzalkonium chloride and glutaraldehyde in a dental nurse. Contact Dermatitis, 1993; 28(2): 127.
21.
Kiec-SwierczynskaM, KreciszB. Occupational skin diseases among the nurses in the region of Lódź. Int J Occup Med Environ Health, 2000; 13(3): 179–184.
22.
SunejaT, BelsitoDV. Occupational dermatoses in health care workers evaluated for suspected allergic contact dermatitis. Contact Dermatitis, 2008; 58(5): 285–290.
BasketterDA, MarriottM, GilmourNJ, et al.Strong irritants masquerading as skin allergens: the case of benzalkonium chloride. Contact Dermatitis, 2004; 50(4): 213–217.
25.
DaoH Jr, FrickerC, NedorostST. Sensitization prevalence for benzalkonium chloride and benzethonium chloride. Dermatitis, 2012; 23(4): 162–166.
26.
LeeSS, HongDK, JeongNJ, et al.Multicenter study of preservative sensitivity in patients with suspected cosmetic contact dermatitis in Korea. J Dermatol, 2012; 39(8): 677–681.
27.
UterW, LessmannH, GeierJ, et al.Is the irritant benzalkonium chloride a contact allergen? A contribution to the ongoing debate from a clinical perspective. Contact Dermatitis, 2008; 58(6): 359–363.
28.
WentworthAB, YianniasJA, KeelingJH, et al.Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010). J Am Acad Dermatol, 2014; 70(2): 269–275.e4.
29.
DavisMD, ScalfLA, YianniasJA, et al.Changing trends and allergens in the patch test standard series: a Mayo Clinic 5-year retrospective review, January 1, 2001, through December 31, 2005. Arch Dermatol, 2008; 144(1): 67–72.
30.
WetterDA, DavisMD, YianniasJA, et al.Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998–2000. J Am Acad Dermatol, 2005; 53(3): 416–421.
31.
BieblKA, WarshawEM. Allergic contact dermatitis to cosmetics. Dermatol Clin, 2006; 24(2): 215–232, vii.
32.
TomarJ, JainVK, AggarwalK, et al.Contact allergies to cosmetics: testing with 52 cosmetic ingredients and personal products. J Dermatol, 2005; 32(12): 951–955.
33.
HamiltonT, de GannesGC. Allergic contact dermatitis to preservatives and fragrances in cosmetics. Skin Therapy Lett, 2011; 16(4): 1–4.
34.
WetterDA, YianniasJA, PrakashAV, et al.Results of patch testing to personal care product allergens in a standard series and a supplemental cosmetic series: an analysis of 945 patients from the Mayo Clinic Contact Dermatitis Group, 2000–2007. J Am Acad Dermatol, 2010; 63(5): 789–798.
35.
BenjaminB, ChrisF, SalvadorG, et al.Visual and confocal microscopic interpretation of patch tests to benzethonium chloride and benzalkonium chloride. Skin Res Technol, 2012; 18(3): 272–277.
36.
BoyvatA, AkyolA, GürgeyE. Contact sensitivity to preservatives in Turkey. Contact Dermatitis, 2005; 52(6): 329–332.
37.
FuchsT, MeinertA, AbererW, et al.Benzalkonium chloride: a relevant contact allergen or irritant? Results of a multicenter study of the German Contact Allergy Group [in German]. Hautarzt, 1993; 44(11): 699–702. German.
38.
WilkinsonDS, FregertS, MagnussonB, et al.Terminology of contact dermatitis. Acta Derm Venereol, 1970; 50(4): 287–292.
39.
BraschJ, HenselerT. The reaction index: a parameter to assess the quality of patch test preparations. Contact Dermatitis, 1992; 27(3): 203–204.
40.
GeierJ, UterW, LessmannH, et al.The positivity ratio: another parameter to assess the diagnostic quality of a patch test preparation. Contact Dermatitis, 2003; 48(5): 280–282.
41.
WarshawEM, NelsenDD, SassevilleD, et al.Positivity ratio and reaction index: patch-test quality-control metrics applied to the North American Contact Dermatitis Group database. Dermatitis, 2010; 21(2): 91–97.
42.
SchnuchA, UterW, GeierJ, et al.Contact allergies in healthcare workers: results from the IVDK. Acta Derm Venereol, 1998; 78(5): 358–363.
43.
NettisE, ColanardiMC, SoccioAL, et al.Occupational irritant and allergic contact dermatitis among healthcare workers. Contact Dermatitis, 2002; 46(2): 101–107.
MarrakchiS, MaibachHI. What is occupational contact dermatitis? An operational definition. Dermatol Clin, 1994; 12(3): 477–484.
46.
KleinGF, SeppN, FritschP. Allergic reactions to benzalkonium chloride?. Do the use test! Contact Dermatitis, 1991; 25(4): 269–270.
47.
SchnuchA, GeierJ, UterW, et al.Patch testing with preservatives, antimicrobials and industrial biocides: results from a multicentre study. Br J Dermatol, 1998; 138(3): 467–476.
WillisCM, StephensCJ, WilkinsonJD. Epidermal damage induced by irritants in man: a light and electron microscopic study. J Invest Dermatol, 1989; 93(5): 695–699.
50.
WillisCM, StephensCJ, WilkinsonJD. Differential patterns of epidermal leukocyte infiltration in patch test reactions to structurally unrelated chemical irritants. J Invest Dermatol, 1993; 101(3): 364–370.
51.
BjornbergA. Skin reactions to primary irritants and predisposition to eczema. Br J Dermatol, 1974; 91(4): 425–427.
52.
BjornbergA. Increased skin reactivity to primary irritants provoked by hand eczema. Arch Dermatol Forsch, 1974; 249(4): 389–400.
53.
SaitoK, NukadaY, TakenouchiO, et al.Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis. Toxicol In Vitro, 2013; 27(8): 2213–2224.
54.
GerberickGF, CruseLW, MillerCM, et al.Selective modulation of B-cell activation markers CD86 and I-Ak on murine draining lymph node cells following allergen or irritant treatment. Toxicol Appl Pharmacol, 1999; 159: 142–151.
55.
YorkM, GriffithsHA, WhittleE, et al.Evaluation of a human patch test for the identification and classification of skin irritation potential. Contact Dermatitis, 1996; 34(3): 204–212.
